^
Association details:
Biomarker:No biomarker
Cancer:Small Intestinal Carcinoma
Drug:capecitabine (Thymidylate synthase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Small Bowel Adenocarcinoma: Adjuvant therapy regimens…Capecitabine